Gynecology Second Department (Gynecological Oncology Center)
Committed to teaching, and clinical and scientific research of gynecological malignant tumors, the Gynecology Second Department (Gynecological Oncology Center) is a key sub-specialty department of the Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University), or CQHCWC.
Following more than 40 years of development, the department has reached a high medical level in the diagnosis and treatment of gynecological tumors. The center became an independent department in February 2023, focusing on the diagnosis, treatment and research of all kinds of gynecological tumors. It adheres to the "patient-centered" concept and will always offer a high level of medical service to its patients.
The department currently has 30 medical staff members, including 18 nurses and 12 doctors, among which, one is a chief physician and five are deputy chief physicians. Three staff members either have a doctorate or are doctoral candidates.
The center has published more than 30 papers in Fertility and Sterility, Oxidative Medicine and Cellular Longevity, J Minim Invasive Gynecol, and other international and national journals. It has also presided over five national and municipal projects.
For the diagnosis and treatment of benign and malignant gynecological tumors, the department adopts a diagnosis and treatment mode based on multi-disciplinary discussion and individual choices, making full use of surgery, chemotherapy, immune-targeted therapy, and clinical research.
The center focuses on the radical resection of cervical cancer, the staging of endometrial cancer, ovarian cancer reduction, the staging of cervical cancer and other gynecological malignant tumor surgeries, all of which are minimally invasive and standardized.
It routinely carries out all kinds of uterine and ovarian tumor surgeries, as well as trophoblastic tumor chemotherapy. It can also carry out screenings, consultations and follow-up work for all kinds of gynecological tumors, to ensure the accuracy and continuity of a patient's gynecological tumor treatment.